Multimodal imaging and treatment of bone metastasis
Eric L Kaijzel1, Thomas J A Snoeks, Jeroen T Buijs
1Department of Endocrinology, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands. E.L.Kaijzel@lumc.nl
Abstract:
The role of molecular imaging in pre-clinical research is continuously evolving. Particularly in small animal models in biomedical research, optical imaging technologies are frequently used to visualize normal as well as aberrant cellular processes at a molecular-genetic or cellular level of function. Also in cancer metastasis research, whole body bioluminescent and fluorescent imaging techniques have become indispensable tools that allow non-invasive and real-time imaging of gene expression, tumor progression and metastasis, and response to therapeutic intervention. In this paper, we discuss the use of optical imaging strategies--either alone or in combination with CT--to study intrabone tumor growth, tumor progression and to monitor efficacy of therapeutic agents in metastatic bone disease.
Insights
Optical imaging aids pre-clinical research by visualizing cellular processes in small animal models. This technology is crucial for studying cancer metastasis, tumor growth, and therapeutic responses in bone disease.
Area of Science:
- Biomedical research
- Molecular imaging
- Pre-clinical studies
Background:
- Optical imaging technologies are vital in pre-clinical research, especially in small animal models.
- These techniques visualize cellular processes at a molecular-genetic or cellular level.
- Whole body bioluminescent and fluorescent imaging are essential for cancer metastasis research.
Purpose of the Study:
- To discuss optical imaging strategies for studying intrabone tumor growth.
- To evaluate tumor progression monitoring using optical imaging.
- To assess the efficacy of therapeutic agents in metastatic bone disease.
Main Methods:
- Utilizing optical imaging strategies, alone or combined with CT.
- Non-invasive, real-time imaging of gene expression and tumor progression.
- Monitoring response to therapeutic interventions in metastatic bone disease models.
Main Results:
- Optical imaging enables detailed study of intrabone tumor growth and progression.
- Bioluminescent and fluorescent imaging provide real-time insights into metastasis.
- Therapeutic efficacy in metastatic bone disease can be effectively monitored.
Conclusions:
- Optical imaging is an indispensable tool in pre-clinical cancer metastasis research.
- Combined optical and CT imaging offers comprehensive insights into bone metastasis.
- These imaging strategies are crucial for evaluating novel therapeutic agents.
